The clinical safety of H1-receptor antagonists. An EAACI position paper.
Passalacqua
G
G
DIMI Department of Internal Medicine, Genoa University, Italy.
Bousquet
J
J
Bachert
C
C
Church
M K
MK
Bindsley-Jensen
C
C
Nagy
L
L
Szemere
P
P
Davies
R J
RJ
Durham
S R
SR
Horak
F
F
Kontou-Fili
K
K
Malling
H J
HJ
van Cauwenberge
P
P
Canonica
G W
GW
D016907:Adverse Drug Reaction Reporting Systems; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D004353:Drug Evaluation, Preclinical; D006634:Histamine H1 Antagonists / Q000009:adverse effects* / Q000145:classification; D006801:Humans; D051379:Mice; D009369:Neoplasms / Q000139:chemically induced; D018579:Patient Selection; D012449:Safety; D012894:Sleep Stages / Q000187:drug effects
D006634:Histamine H1 Antagonists